{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:22:03Z","timestamp":1778934123163,"version":"3.51.4"},"reference-count":40,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":3430,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n                  <jats:sec>\n                     <jats:title>OBJECTIVE<\/jats:title>\n                     <jats:p>Disordered mineral metabolism is a common complication of chronic kidney disease (CKD) and a novel risk factor for CKD progression, cardiovascular disease, and mortality. Although diabetes is the leading cause of CKD and is associated with worse clinical outcomes than other etiologies, few studies have evaluated mineral metabolism in CKD according to diabetes status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                     <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                     <jats:p>Using the Chronic Renal Insufficiency Cohort Study, we tested the hypothesis that diabetes is independently associated with lower serum calcium and higher serum phosphate, parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                     <jats:title>RESULTS<\/jats:title>\n                     <jats:p>Compared with participants without diabetes (n = 1,936), those with diabetes (n = 1,820) were more likely to have lower estimated glomerular filtration rate (eGFR), lower serum albumin, and higher urinary protein excretion (all P &amp;lt; 0.001). Unadjusted serum phosphate, PTH, and FGF23 levels were higher and calcium was lower among those with compared with those without diabetes (all P &amp;lt; 0.001). After multivariate adjustment, diabetes remained a significant predictor of serum phosphate, PTH, and FGF23 but not calcium. The eGFR cut point at which 50% of participants met criteria for secondary hyperparathyroidism or elevated FGF23 was higher in participants with diabetes compared with those without (PTH: eGFR 30\u201339 vs. 20\u201329, P &amp;lt; 0.001; FGF23: eGFR 50\u201359 vs. 40\u201349, P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                     <jats:title>CONCLUSIONS<\/jats:title>\n                     <jats:p>Disordered mineral metabolism begins earlier in the course of CKD and is more severe among CKD patients with compared with those without diabetes. Future studies should explore mechanisms for these differences and whether they contribute to excess risks of adverse clinical outcomes among diabetic patients with CKD.<\/jats:p>\n                  <\/jats:sec>\n               <\/jats:sec>","DOI":"10.2337\/dc11-2235","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T04:08:03Z","timestamp":1332562083000},"page":"994-1001","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":67,"title":["Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease"],"prefix":"10.2337","volume":"35","author":[{"given":"Patricia","family":"Wahl","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiliang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Scialla","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"The Welch Center for Prevention, Epidemiology, and Clinical Research and the Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Bellovich","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, St. John Hospital and Medical Center, Detroit, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Brecklin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Illinois at Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana"},{"name":"Department of Epidemiology, Tulane University Health Sciences Center, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Feldman","sequence":"additional","affiliation":[{"name":"The Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"},{"name":"Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando M.","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Lash","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Illinois at Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Leonard","sequence":"additional","affiliation":[{"name":"The Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"},{"name":"The Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavinia","family":"Negrea","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia E.","family":"Rosas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Hyre","family":"Anderson","sequence":"additional","affiliation":[{"name":"The Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond R.","family":"Townsend","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Chronic Renal Insufficiency Cohort Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2012,4,11]]},"reference":[{"key":"2022031302334801600_B1","author":"Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention,","year":"2011"},{"key":"2022031302334801600_B2","volume-title":"USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","author":"U.S. Renal Data System","year":"2010"},{"key":"2022031302334801600_B3","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"de Boer","year":"2011","journal-title":"JAMA"},{"key":"2022031302334801600_B4","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"2022031302334801600_B5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2022031302334801600_B6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031302334801600_B7","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2022031302334801600_B8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2215\/CJN.07810910","article-title":"Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction","volume":"6","author":"Bellasi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031302334801600_B9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jbmr.5650020609","article-title":"Bone histomorphometry of renal osteodystrophy in diabetic patients","volume":"2","author":"Andress","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2022031302334801600_B10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ki.1984.73","article-title":"Parathyroid and bone response of the diabetic patient to uremia","volume":"25","author":"Vincenti","year":"1984","journal-title":"Kidney Int"},{"key":"2022031302334801600_B11","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods","volume":"14","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2022031302334801600_B12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2011.05.010","article-title":"CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC studies","volume":"58","author":"Fischer","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2022031302334801600_B13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/aje\/154.12.1089","article-title":"Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America\u2019s Table Study","volume":"154","author":"Subar","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2022031302334801600_B14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2022031302334801600_B15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2022031302334801600_B16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"2022031302334801600_B17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/jc.2010-0980","article-title":"Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?","volume":"96","author":"Thrailkill","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031302334801600_B18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ndt\/13.suppl_3.9","article-title":"Is there a lesser hyperparathyroidism in diabetic patients with chronic renal failure?","volume":"13","author":"Mart\u00ednez","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"2022031302334801600_B19","first-page":"311","article-title":"Relative hyperphosphaturia in diabetic chronic renal failure: a protective factor of hyperparathyroidism","volume":"13","author":"Aubia","year":"1987","journal-title":"Miner Electrolyte Metab"},{"key":"2022031302334801600_B20","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","article-title":"Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease","volume":"21","author":"Manghat","year":"2010","journal-title":"Osteoporos Int"},{"key":"2022031302334801600_B21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bone.2009.07.016","article-title":"The impact of diabetes mellitus on vitamin D metabolism in predialysis patients","volume":"45","author":"Tanaka","year":"2009","journal-title":"Bone"},{"key":"2022031302334801600_B22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: a prospective study","volume":"86","author":"Schwartz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031302334801600_B23","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","article-title":"Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women","volume":"24","author":"Nicodemus","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031302334801600_B24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s001250051248","article-title":"Diabetes mellitus and the incidence of hip fracture: results from the Nord-Tr\u00f8ndelag Health Survey","volume":"42","author":"Fors\u00e9n","year":"1999","journal-title":"Diabetologia"},{"key":"2022031302334801600_B25","doi-asserted-by":"crossref","first-page":"M648","DOI":"10.1093\/gerona\/57.10.M648","article-title":"Diabetes mellitus as a risk factor for hip fracture in Mexican American older adults","volume":"57","author":"Ottenbacher","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022031302334801600_B26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/aje\/155.10.926","article-title":"Foot problems as risk factors of fractures","volume":"155","author":"Keegan","year":"2002","journal-title":"Am J Epidemiol"},{"key":"2022031302334801600_B27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/acta.0.0960081","article-title":"Hypoparathyroidism in diabetes mellitus","volume":"96","author":"McNair","year":"1981","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2022031302334801600_B28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/acta.0.0900463","article-title":"Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis","volume":"90","author":"McNair","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2022031302334801600_B29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/j.ajkd.2011.04.029","article-title":"Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD","volume":"58","author":"Ure\u00f1a-Torres","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2022031302334801600_B30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2022031302334801600_B31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s11255-008-9462-4","article-title":"Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis","volume":"40","author":"Kojima","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"2022031302334801600_B32","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","article-title":"Bone formation regulates circulating concentrations of fibroblast growth factor 23","volume":"150","author":"Samadfam","year":"2009","journal-title":"Endocrinology"},{"key":"2022031302334801600_B33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ki.2010.404","article-title":"Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-\u03b2-D-glucosaminidase","volume":"79","author":"Vaidya","year":"2011","journal-title":"Kidney Int"},{"key":"2022031302334801600_B34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.diabres.2009.06.022","article-title":"Are low erythropoietin and 1,25-dihydroxyvitamin D levels indicative of tubulo-interstitial dysfunction in diabetes without persistent microalbuminuria?","volume":"85","author":"Singh","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031302334801600_B35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ki.2010.375","article-title":"Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate","volume":"79","author":"Pavik","year":"2011","journal-title":"Kidney Int"},{"key":"2022031302334801600_B36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"2022031302334801600_B37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"2022031302334801600_B38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/ajplegacy.1926.76.3.525","article-title":"The relationship of phosphate and carbohydrate metabolism.III. The effect of glucose on the excretion of phosphate in depancreatized dogs","volume":"76","author":"Markowitz","year":"1926","journal-title":"Am J Physiol"},{"key":"2022031302334801600_B39","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/dc10-0917","article-title":"The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease","volume":"33","author":"Ng","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031302334801600_B40","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc11-0203","article-title":"Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients","volume":"34","author":"Rognant","year":"2011","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/35\/5\/994\/612645\/994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/35\/5\/994\/612645\/994.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T01:48:22Z","timestamp":1647136102000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/35\/5\/994\/38469\/Earlier-Onset-and-Greater-Severity-of-Disordered"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,11]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,4,11]]},"published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc11-2235","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,11]]}}}